Direct Cytosolic Delivery of Proteins through Coengineering of Proteins and Polymeric Delivery Vehicles
- 25 February 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 142 (9) , 4349-4355
Abstract
Nanocarrier-mediated protein delivery is a promising strategy for fundamental research and therapeutic applications. However, the efficacy of current platforms for delivery into cells is limited by endosomal entrapment of delivered protein cargo, with concomitantly inefficient access to the cytosol and other organelles, including the nucleus. We report here a robust, versatile polymeric-protein nanocomposite (PPNC) platform capable of efficient (≥90%) delivery of proteins to the cytosol. We syn-thesized a library of guanidinium-functionalized poly(oxanorborneneimide) (PONI) homopolymers with varying molecular weights to stabilize and deliver engineered proteins featuring terminal oligoglutamate “E-tags”. The polymers were screened for cytosolic delivery efficiency using imaging flow cytometry, with cytosolic delivery validated using confocal microscopy, and activity of the delivered proteins demonstrated through functional assays. These studies indicate that the PPNC platform provides highly effective and tunable cytosolic delivery over a wide range of formulations, making them robust agents for therapeutic protein delivery.Keywords
Funding Information
- National Institutes of Health (EB022641, GM008515)
- National Science Foundation (CHE-1808199)
This publication has 44 references indexed in Scilit:
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of MetastasisCancer Cell, 2016
- Initiation of T cell signaling by CD45 segregation at 'close contacts'Nature Immunology, 2016
- Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsiaNature Genetics, 2015
- 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyondNature Reviews Molecular Cell Biology, 2014
- Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and AgingInternational Journal of Cell Biology, 2013
- Metabolic Pathways in Immune Cell Activation and QuiescenceImmunity, 2013
- 2012 FDA drug approvalsNature Reviews Drug Discovery, 2013
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Protein aggregation diseases: pathogenicity and therapeutic perspectivesNature Reviews Drug Discovery, 2010
- Protein Lipidation in Cell SignalingScience, 1995